Increased umbilical cellular fibronectin concentrations are associated with a decreased prevalence of growth restriction in preeclampsia

Journal of the Society for Gynecologic Investigation

Volumn 6, Issue 5, 1999, Pages 264-267

  Gilmour, Carol H ^a   Patrick, Thelma E ^a,b   Roberts, James M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cellular fibronectin; Endothelial activation; Fetal growth; Intrauterine growth restriction; Preeclampsia

Indexed keywords

FIBRONECTIN;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS GROWTH; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; NEWBORN; PREECLAMPSIA; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FETAL GROWTH RETARDATION; FIBRONECTINS; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; REGRESSION ANALYSIS; UMBILICAL CORD;

EID: 0032748013     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00026-X     Document Type: Article

References (11)

1. Roberts J.M., Redman C.W. Pre-eclampsia More than pregnancy-induced hypertension . Lancet. 341:1993;1447-1451.
2. Friedman S.A., De Groot C.J.M., Taylor R.N., Golditch B.D., Roberts J.M. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol. 170:1994;838-841.
3. Peters J.H., Maunder R.J., Woolf A.D., Cochrane C.G., Ginsberg M.H. Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med. 113:1989;586-597.
4. Davidge S.T., Signorella A.P., Lykins D.L., Gilmour C.H., Roberts J.M. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol. 175:1996;1301-1306.
5. Metcoff J. Clinical assessment of nutritional status at birth Fetal malnutrition and SGA are not synonymous . Pediatr Clin North Am. 41:1994;875-891.
6. Murphy-Ullrich J.E., Mosher D.F. Fibronectin and Disease Processes. Uitto J., Perejda A.J. Connective tissue disease molecular pathology of the extracellular matrix . 1986;455-473 Marcel Dekker, New York.
7. Friedman S.A., Schiff E., Emeis J.J., Dekker G.A., Kao L., Sibai B.M. Fetal plasma levels of cellular fibronectin as a measure of fetal endothelial involvement in preeclampsia. Obstet Gynecol. 89:1997;46-48.
8. de Jager C.A., Shephard E.G., Robson S.C., Jaskiewicz K., Froese S., Anthony J., et al. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. J Lab Clin Med. 125:1995;522-530.
9. Walther F.J., Ramaekers L.H.J. The Ponderal Index as a measure of the nutritional status at birth and its relation to some aspects of neonatal morbidity. J Perinat Med. 10:1982;42-47.
10. Kramer M.S., McLean F.H., Olivier M., Willis D.M., Usher R.H. Body proportionality and head and length 'sparing' in growth-retarded neonates A critical reappraisal . Pediatrics. 84:1989;717-723.
11. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol. 68:1993;495-532.